Unrelated DonorsTransplantation, HomologousHematopoietic Stem Cell TransplantationGraft vs Host DiseaseTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsTissue DonorsHistocompatibility TestingMyeloablative AgonistsStem CellsHistocompatibilityHematopoietic Stem CellsTransplantation ChimeraGraft vs Leukemia EffectBone Marrow TransplantationGraft vs Tumor EffectEmbryonic Stem CellsVidarabineBusulfanPeripheral Blood Stem Cell TransplantationAdult Stem CellsRemission InductionTreatment OutcomeLeukemiaRecurrenceLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell DifferentiationCytomegalovirus InfectionsTransplantation, AutologousPluripotent Stem CellsGraft SurvivalBone Marrow CellsLymphocyte TransfusionBlood DonorsMinor Histocompatibility AntigensSiblingsLymphocyte DepletionStem Cell NicheWhole-Body IrradiationAntigens, CD34Immunosuppressive AgentsHematopoiesisVirus ActivationT-LymphocytesLiving DonorsMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesHematopoietic Stem Cell MobilizationInduced Pluripotent Stem CellsStem Cell FactorNeoplasm, ResidualCells, CulturedAntilymphocyte SerumNeural Stem CellsMultiple MyelomaChimerismSalvage TherapySurvival AnalysisCytomegalovirusTime FactorsMultipotent Stem CellsCell LineageFlow CytometrySurvival RateCombined Modality TherapyFusion Proteins, bcr-ablMesenchymal Stem Cell TransplantationPrimary MyelofibrosisMesenchymal Stromal CellsDisease-Free SurvivalMice, Inbred C57BLHematopoietic SystemAnemia, AplasticCord Blood Stem Cell TransplantationRoseolovirus InfectionsAcute DiseaseBone MarrowTrans Fatty AcidsLeukemia, MyeloidBenzamidesCell ProliferationLeukemia, Myeloid, Accelerated PhaseHepatic Veno-Occlusive DiseaseAntigens, CDPyrimidinesCell SeparationHLA AntigensCyclophosphamideAntibodies, NeoplasmLeukocyte TransfusionTransplantation ImmunologyAntineoplastic AgentsGranulocyte Colony-Stimulating FactorReceptors, Purinergic P2X5Hematologic DiseasesPiperazinesImmunotherapy, Adoptive